<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>valganciclovir &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/valganciclovir/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 13:31:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>valganciclovir &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Low White Blood Cell Counts After Kidney Transplant Linked to Higher Costs and CMV Timing</title>
		<link>https://bioengineer.org/low-white-blood-cell-counts-after-kidney-transplant-linked-to-higher-costs-and-cmv-timing/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 13:31:14 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[CMV DNAemia]]></category>
		<category><![CDATA[cytomegalovirus]]></category>
		<category><![CDATA[donor-recipient serostatus]]></category>
		<category><![CDATA[Finland]]></category>
		<category><![CDATA[healthcare resource utilization]]></category>
		<category><![CDATA[kidney transplantation]]></category>
		<category><![CDATA[leukopenia]]></category>
		<category><![CDATA[myelosuppression]]></category>
		<category><![CDATA[neutropenia]]></category>
		<category><![CDATA[registry study]]></category>
		<category><![CDATA[transplant immunosuppression]]></category>
		<category><![CDATA[valganciclovir]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=427691</guid>

					<description><![CDATA[A Finnish registry study of 966 kidney transplant recipients found that post-transplant leukopenia and neutropenia were most common in CMV high-risk donor-positive recipient-negative patients and were linked to increased healthcare utilization and costs.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">427691</post-id>	</item>
	</channel>
</rss>
